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Abstract 
Effective systems for the analysis of molecular data are of fundamental importance for             
real-time monitoring of the spread of infectious diseases and the study of pathogen             
evolution. While the Nextstrain and GISAID portals offer widely used systems for the             
classification of SARS-CoV-2 genomes, both present relevant limitations. Here we propose           
a highly reproducible method for the systematic classification of SARS-CoV-2 viral types. To             
demonstrate the validity of our approach, we conduct an extensive comparative genomic            
analysis of more than 20,000 SARS-CoV-2 genomes. Our classification system delineates           
12 clusters and 4 super-clusters in SARS-CoV-2, with a highly biased spatio-temporal            
distribution worldwide, and provides important observations concerning the evolutionary         
processes associated with the emergence of novel viral types. Based on the estimates of              
SARS-CoV-2 evolutionary rate and genetic distances of genomes of the early pandemic            
phase, we infer that SARS-CoV-2 could have been circulating in humans since            
August-November 2019. The observed pattern of genomic variability is remarkably similar           
between all clusters and super-clusters, being UTRs and the s2m element, a highly             
conserved secondary structure element, the most variable genomic regions. While several           
polymorphic sites that are specific to one or more clusters were predicted to be under               
positive or negative selection, overall, our analyses also suggest that the emergence of             
novel genome types is unlikely to be driven by widespread convergent evolution and             
independent fixation of advantageous substitutions. While, in the absence of rigorous           
experimental validation, several questions concerning the evolutionary processes and the          
phenotypic characteristics (increased/decreased virulence) remain open, we believe that the          
approach outlined in this study can be of relevance for the tracking and functional              
characterization of different types of SARS-CoV-2 genomes. 
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Introduction 
The ongoing Coronavirus disease 2019 (COVID-19) pandemic [1] poses the greatest global            
health and socioeconomic threat since world war II. The first case of COVID-19 was              
reported in Wuhan city, Hubei province, China, in late December 2019 [2], although             
retrospective analyses have placed the onset as early as December 1st.  
The most common symptoms include fever, dry-cough and a general sense of fatigue, while              
some patients also experience muscle pain, nasal congestion, runny nose, sore throat, or             
diarrhoea [3-4]. In a minority of the patients the infection may cause pneumonia, severe              
acute respiratory syndrome, kidney failure and even death [5-6]. Symptoms are usually mild             
in children and young adults , while elderly, immunosuppressed, and individuals affected by             
a cardiac disease or diabetes are at higher risk of developing severe symptoms [7].  
COVID-19 is primarily transmitted between people through respiratory droplets and contact           
routes [8], although some recent studies suggest that airborne transmission might also be             
possible [9-10]. The incubation period typically ranges between 2 and 14 days, although             
longer incubation times have been also reported [11]. Notwithstanding the development of            
several promising therapeutic approaches [12], at present no universally approved          
therapeutic strategy is available for the treatment of COVID-19.  
 
At the time of writing, COVID-19 has affected more than 200 countries worldwide, with more               
than 9 Million confirmed individual infections and a death toll in excess of 480 thousand. The                
limited availability of diagnostic kits in several countries, varying criteria for reporting            
COVID-19-related deaths, and the fact that very mild or asymptomatic infections can often             
go undetected [13], suggest that both these figures are likely to represent substantial             
underestimates of the worldwide impact of SARS-CoV-2. The first complete genomic           
sequences of the viral pathogen were determined in early January 2020 by Next Generation              
Sequencing metatranscriptomics [14], allowing the rapid development of diagnostic tests          
(Corman et al., 2020) and the development of molecular monitoring strategies [15-16].  
The genome is approximately 30.000 nt in size and shows high similarity (~79%) with              
SARS-CoV [17], a beta-coronavirus of the subgenus Sarbecovirus, and the causal agent of             
a large scale epidemic of viral pneumonia (Severe Acute Respiratory Syndrome, SARS)            
that hit China and other 25 countries in 2003 and 2004 [18]. The International Committee               
on Taxonomy of Viruses (ICTV) has designated the novel pathogen as SARS-CoV-2.            
Phylogenetic analyses of conserved protein domains of more than 2500 coronaviruses have            
been used to assign SARS-CoV-2 to the group of the Severe acute respiratory             
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syndrome-related coronavirus species (SARSr-CoV), where it forms a relatively distant sister           
group to SARS-CoV, interleaved with various SARSr-CoV isolated from non-human          
mammalian species [19].  
SARS-CoV-2 shows the highest levels of genome identity (96%) with a bat SARS-related             
(SARS-r) CoV denoted RaTG13, isolated in the Yunnan province [20]. Despite this            
sequence similarity, SARS-CoV-2 differs from RaTG13 in several key features. Arguably, the            
most important is the presence of a polybasic furin cleavage site insertion (residues PRRA)              
at the junction of the S1 and S2 subunits of the Spike protein [21]. This insertion, which may                  
increase the infectivity of the virus, is not present in related beta-coronaviruses, although             
similar polybasic insertions are observed in other human coronaviruses, including          
HCoV-HKU1, as well as in highly pathogenic strains of avian influenza virus [22].             
Additionally, the RBD (Recognition Binding Domain) of the SARS-CoV-2 spike protein is            
significantly more similar (97% identity) to that of SARSr-CoVs isolated from specimens of             
Malayan pangolins (​Manis javanica​) illegally imported into southern China (Guangdong and           
Guangxi provinces) than to the RDB of RaTG13 (​89% identity​). This data suggest the              
possibility that pangolins or other mammalian species could have acted as “intermediate” or             
“amplifying” hosts for human transmission of SARS-CoV-2 [23-24].  
As the COVID-19 pandemic has progressed, the number of viral isolates for which a              
genomic sequence is available has increased substantially. Currently, in the excess of            
50.000 viral genomes are publicly available in dedicated repositories [25]. As expected,            
considering the recent ancestry, and reportedly low mutation rates of coronaviruses [26],            
SARS-CoV-2 genomes are highly similar (average identity 99.99% ) and show reduced            
genetic diversity. This low diversity notwithstanding, the availability of a considerable number            
of genomic sequences, with worldwide sampling, allows the identification of phylogenetically           
distinct clusters of SARS-CoV-2 sequences [27-32]. Interestingly, several of these clusters           
show highly biased geographic distributions, and in many independent studies, the genomic            
signatures of different clusters have been tentatively linked to increased/decreased virulence           
or possible adaptation to human hosts [33-35].  
While it should be stressed that, in the absence of careful experimental validation, it is               
extremely difficult to determine if the identified SARS-CoV-2 genetic variants have           
increased/decreased virulence and reflect adaptive evolution or genetic drift and founder           
effects, the importance of establishing a simple and reproducible system for the delineation             
of genomic diversity of human pathogens is universally acknowledged [36-37]. Indeed such            
a classification system could be extremely useful for the rapid identification of new emerging              
types and, more importantly, for a fine grained monitoring of the diffusion of pathogens in               
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different geographic contexts over time. 
Currently, the most widely used models for the classification of SARS-CoV-2 viral types are              
those provided by the curators of the GISAID [38] and Netxstrain portals [39], which              
incorporate the most complete and accurate resources for comparative genomics of           
SARS-CoV-2, Providing extensive databases of more than 40000 viral sequences with           
associated metadata, including date and place of isolation, as well as information concerning             
health and background data of the patients. GISAID also provides tools for comparative             
genomic and phylogenetic analyses to facilitate the annotation of the genomes, their            
classification in types/groups and the functional interpretation of the data. Similarly,           
Nexstrain collects a selection of publicly available genomes and associated metadata, to            
provide informative analyses and graphical representation of the spread of SARS-CoV-2           
over time as well as detailed and curated phylogenetic analyses for the classification of              
genome types. Although both platforms constitute invaluable resources for the SARS-CoV-2           
research community, the associated classification systems suffer from some inherent          
limitations. The most important is that the criteria used to establish the clusters/types of              
SARS-CoV-2 are not set out clearly, and that the delineation of clusters is based on               
arbitrary manual annotation of phylogenetic trees, rather than on inherent genomic features            
of SARS-CoV-2, limiting the reproducibility of results. Furthermore, Nextstrain provides          
classification only for a restricted selection of the available viral genomes (currently less than              
4000). Finally, limited variability and the recurrent events of recombination observed in            
Sarbecovirus [40-41] may hinder the validity of classification systems based purely on            
phylogenetic analyses and manual annotation.  
In the light of these considerations, in the present work we propose a simple set of rules,                 
which could serve as an operational classification system of SARS-CoV-2 genomic           
sequences. The proposed classification system is inspired by MultiLocus Strain Typing           
(MLST), a classification approach normally used for microbes [​42]​. Thus, for a given dataset              
of available SARS-CoV-2 genomes, it combines the empirical study of genomic variability            
with the analyses of the high frequency variant sites that are fixed in the extant viral                
population. In this way our approach derives a simple but effective set of rules for a                
systematic and highly reproducible delineation of SARS-CoV-2 genomes, that are therefore           
grouped in clusters and superclusters. 
To demonstrate the validity of our approach, we conducted an extensive comparative            
genomic analysis of more than 20,000 SARS-CoV-2 complete genomes. By applying the            
proposed classification system we derived important observations concerning different types          
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of SARS-CoV-2, their evolutionary pattern and geographic distribution, and the mechanisms           
associated with the emergence of possible novel types.  
 
Materials and methods 
A collection of 20,521 putatively complete high coverage SARS-CoV-2 genomes and           
associated metadata was retrieved from the GISAID EpicoV [38] platform on 28th May             
2020. A total of 13 SARSr-CoV genomic sequences isolated from non-human hosts,            
including bats and pangolins [23-24], were also retrieved from the GISAID EpiCoV portal at              
the same date. SARS-CoV-2 sequence comparisons were performed using the reference           
Refseq [43] assembly NC_045512.2, collected on 26th December 2019 and identical to the             
sequence of the oldest SARS-CoV-2 isolates, dating back to 24th December 2019            
(EPI_ISL_402123). 
SARS-CoV-2 genomes were aligned to the 29,903 nt-long reference assembly of           
SARS-CoV-2 by means of the ​nucmer program [44]. Custom Perl scripts were used to infer               
the size of each genomic assembly and the number of uncalled bases/gaps (denoted by N in                
the genomic sequence). Then, we analysed only the 11,633 high quality complete genomes,             
defined as those longer than 29,850 nt and including less than 150 ambiguous sites. 
Variant sites, including substitutions and small insertion and deletions, were identified by            
using the ​show-snps utility of the ​nucmer package. Output files were processed by the              
means of a custom Perl script, and converted into a phenetic matrix, with variable positions               
on the rows and viral isolates in the columns. Values of 1 and 0 were respectively used to                  
indicate presence or absence of a variant. 
Genetic distances between genomic sequences were established from this phenetic matrix           
using the ​dist function of the R ​stat package with default parameters (Euclidean distances)              
[45-46]. Clusters were established by means of hierarchical clustering algorithms, with           
complete linkage as implemented in the ​hclust R standard libraries function. The ​cutree             
function was used to separate distinct clusters at the desired level of divergence (2 distinct               
variant sites). 
Functional effects of genetic variants, as identified from genome alignments, were predicted            
by means of a custom Perl script, based on the annotation of the NC_045512.2              
SARS-CoV-2 reference assembly. 
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Identification of sites possibly under selection was performed by applying the MEME and             
FEL methods, as implemented in the ​Hyphy package[47], on the concatenated alignment of             
protein coding sequences of all the 11,633 previously identified high quality complete            
SARS-CoV-2 genomes. A p-value of 0.05 was considered for the significance threshold. 
A total of 68 viral genomes of the SARS 2003 outbreak were retrieved from the NCBI virus                 
database [48]. Classification/association of strains to the 3 (early/middle/late) phases of the            
SARS 2003 epidemic are according to Song et al 2005 [49]. 
Calculation of evolutionary rates of SARS-CoV-2 and estimation of times of divergence were             
performed according to the formula described in Zhao et al ​[50]​, based on genetic distances               
as determined in this study. 
Analyses of prevalence of allele frequency over time were executed based on the collection              
dates of individual genomes as reported in the GISAID metadata table. The collection date              
of the reference genomic sequence of SARS-CoV-2 in GISAID (26th December 2020), was             
set as time 0. Consecutive, non-overlapped intervals of 10 by 10 days were considered. A               
total of 1381 genomic sequences, for which collection dates were not reported in GISAID,              
were excluded from these analyses. 
Comparison of levels of variability of “early” and “late” clusters of SARS-CoV-2 genomes             
were established by 100 random resampling of 150 genomes (batch), matched by date of              
collection, from each defined cluster (see below). The total number of distinct variant sites              
was calculated for each random batch of genomes, in order to derive a distribution of               
genomic variability. Significance between distributions of genomic diversity were established          
by means of the Wilcoxon, Sum and Rank test as implemented in the standard R libraries                
[45].  
Variability with respect to the reference NC_045512.2 SARS-CoV-2 genome was computed           
on sliding windows of 100 bp, overlapped by 50 bp, by counting the proportion of variable                
sites contained in each window (number of variable sites in the window, divided by the total                
number of variable sites in the entire genome) with a custom Perl script. A Fisher-exact test,                
contrasting the local variability in a window with the average variability in the genome, was               
used to identify hypervariable regions. P-values were corrected using the          
Benjamini-Hochberg procedure for the control of False Discovery Rate. 
Predictions of the secondary structure of the “Coronavirus stem-loop II-like motif” (s2m) and             
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its Minimum Folding Energy (MFE) calculation were estimated with the RNAfold program            
[51] of the Vienna package [52], by artificially implanting each of the possible 129              
substitutions in the 43 nt-long s2m sequence identified in the reference SARS-CoV-2            
genome and in the presumably ancestral sequence of s2m, as observed in the genome of               
the RatG13 SARSr-CoV-2. 
Prediction of the consensus co-folding structure of s2m in SARS-CoV-2 was obtained by             
applying the R-scape[53] program to the alignment of all s2m sequences found in the              
collection of the 11,633 high quality complete genome analysed in this study.  
Consensus secondary structure of the s2m element of Coronaviruses was as in the model              
RF00164 (​https://rfam.org/family/RF00164 ​) of the RFAM database (reference). 
Graphical representation of the data, basic statistical analyses and clustering of viral            
genomes were performed by means of the standard libraries of the R programming             
language.  
The software for the operational classification of SARS-CoV-2 lineages proposed here, is            
publicly available through this github repository      
https://github.com/matteo14c/assign_CL_SARS-CoV-2 ​.  
 
Results 
Genomic features and evolutionary dynamics of SARS-CoV-2 
We retrieved 20,521 SARS-CoV-2 genomic sequences labeled as high coverage and           
putatively complete, covering 86 countries in 5 continents from the GISAID EpiCoV portal.             
Surprisingly, we observed that a considerable number (6462) of the reportedly complete            
genomic assemblies of SARS-CoV-2 presented incomplete 3’ or 5’ UTRs (median size            
29782 nts; reference genome size of 29,903 nts, including a polyA tail of 33 nts).               
Additionally, 4310 genomes contained a large number of gaps and/or uncalled bases -             
ranging from 151 to 3500. Stringent criteria were used to retain only sequences which were               
more likely to represent a nearly complete assembly of the SARS-CoV-2 genome (more than              
29,850 nts in size) and contained only a limited number of missing positions (less than 150                
Ns). A total of 11,633 genomes were therefore selected and analysed (Supplementary Table             
S1).  
Comparative analysis of genetic distances between these SARS-CoV-2 genomes (see          
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Materials and methods) showed an average number of 0.64 variant sites per nearest             
neighbor pair. The equivalent figure for late-phase isolates of SARS-CoV from the SARS             
2003-2004 epidemics [49] was slightly higher (0.78 polymorphic sites per nearest neighbor            
pair). Consistent with these observations, estimates of mutation rates, according to the            
formula described in Zhao et al [50] are marginally lower for SARS-CoV-2 (1.84 x 10 ​-3               
substitutions per site per year) compared to SARS-CoV (2.38 x 10 ​-3 substitutions per site per               
year). Interestingly, we notice that 6384 (54.87%) of the high quality SARS-CoV-2 genomes             
here analysed have a perfect sequence identity (0 polymorphic sites) with respect to their              
closest neighbor. All in all these observations are consistent with the reportedly low mutation              
rate of coronaviruses with respect to other single strand RNA viruses [26,50]. 
 
A total of 6319 distinct variant sites were observed between the 11,633 high quality              
genomes included in these analyses (Supplementary Table S2). 99.22% of these sites have             
an allele frequency below 1%, the threshold above which a variant is often considered fixed               
in a natural population [54]. This value is not surprising, consideringly the relatively recent              
ancestry and the low mutation rate of SARS-CoV-2. Thus, only 50 variant positions (0.88%)              
show an allele frequency of 1% or greater (Table 1).  
Importantly, when the entire collection of 20,521 SARS-CoV-2 genomes considered in this            
study is taken into account, the total number of variant sites is significantly increased (9398               
sites,Supplementary Table S2), but the number and type of high (≥ 1%) frequency variant              
sites remains relatively constant (46), suggesting a robust estimate of allele frequencies for             
these sites. Of note, of the 4 sites that show an apparent reduction in prevalence, 3 are                 
located in the 200 nt of the 3’ terminal end of the genome, while one is positioned within the                   
first 36 nt of the 5’ end (Table 1). This suggests that the apparent reduction in allele                 
frequency at these 4 sites is most probably due to an incomplete representation of the               
terminal ends of the genomes.  
 
Functional annotation of the complete collection of variant sites identified in this study,             
shows a similar proportion of synonymous and nonsynonymous substitutions among the           
6319 low frequency (<1%) variants (50.73% and 49.27% respectively). Conversely, the           
proportion of non synonymous substitutions is increased to 66.6% (OR=1.31, Fisher p-value            
0.159) in the 42 high frequency (≥1%) polymorphic sites associated with protein coding             
genes (Table 1).  
The MEME and FEL methods [47] were applied to the concatenated alignments of protein              
coding genes of the 11,633 high quality complete genomes to identify signals of adaptive              
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evolution. A total of 194 sites were associated (p-value ≤ 0.05) with signatures of selection               
according to at least one method (Supplementary Table S3). Of these, 118 sites were              
associated with positive selection, while 76 sites were deemed to be under negative             
selection. 
Strikingly, a highly significant over-representation of both sites under negative and positive            
selection is observed among the 42 high frequency polymorphic sites of protein coding             
genes (Table 1). In particular, 8 of these sites (OR=8.65, Fisher p-value 4.41e-07) are              
highlighted as evolving under positive selection, while 11 sites (OR=17.82, Fisher p-value            
1.95e-12) were predicted to be under negative selection.  
 
 
An operational classification of SARS-CoV-2 genomes 
An ideal classification system based on molecular data should consider evolutionary           
features of the species under study to identify the minimum level of divergence required to               
delineate different types of genomic sequences. Moreover, to avoid excessive-fragmentation          
each cluster should incorporate a relevant proportion of population. Finally the system            
should be easy to implement and allow the rapid classification of novel specimens as they               
become available. Although the classification systems proposed by GISAID and Nextstrain           
are widely used, we observe that both systems suffer from several limitations, including: 
1. Low reproducibility ​: the rules used to establish different clades of genomes are not             
set out clearly and in a systematic manner. Hence neither existing classification            
systems can be reproduced/re-applied in full and do not allow the automatic            
classification of novel strains; 
2. Presence of polyphyletic groups: although both systems are based on          
phylogenetic approaches, both the Nextstrain and GISAID proposed classification of          
SARS-CoV-2 incorporate polyphyletic groups/clusters of genomes (Supplementary       
Figure S1: see Group G of GISAID; Groups 19A and 20A of Nextstrain); 
3. Bias towards highly abundant genome types: both in GISAID and Nextstrain           
groups of genome are established visually based on the relative abundance of            
groups that populate the phylogeny of SARS-CoV-2. Since sampling of viral           
genomes is not guaranteed to be uniform across countries, and is indeed biased             
even between countries with reportedly similar numbers of affected individuals (i.e           
see for example Italy and UK,Supplementary Table S1) this could result in a             
over-fragmentation of genome types for which a large number of representative           
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sequences are available, but also - and more important - to mis-classification of the              
types of genomes which, for the time being are less represented in the phylogenetic              
tree. This is exemplified by the fact that at present, more than 1500 genomes are not                
assigned to a type according to GISAID. 
 
As outlined in the previous section currently available genomic sequences of SARS-CoV-2            
show a limited level of variability and a low number of high frequency polymorphic sites.               
Moreover, a relatively high proportion of these sites may evolve under adaptive selection,             
possibly consistent with functional consequences of variants. Based on these observations,           
we propose a simple set of empirical rules for the operational classification of SARS-CoV-2              
genomes: 
1. Similar to approaches used for Multi Locus Strain typing [42], classification of            
SARS-CoV-2 genomes should be based on variants that are shared by a relevant             
proportion of viral population. Since a prevalence of 1% is normally considered to             
identify genetic variants that have reached fixation in a population [54], we propose to              
use this cut-off as the natural threshold for identifying high frequency variants .  
2. In the light of the fact that closely related genomes show an average of 0.64               
polymorphic sites, we suggest that distinct clusters/types should differ at least for 2             
high frequency polymorphic sites  
3. To avoid an excessive fragmentation, each cluster/type should incorporate at least           
100 distinct genomes. 
4. Since the variability of SARS-CoV-2 is limited, clusters/types that share one or more             
high frequency polymorphic sites should form groups of higher order (super-cluster). 
 
To evaluate the validity of the proposed clustering approach, we applied the criteria defined              
above for clustering both the 11,633 high quality genomes (high quality set), as defined by               
our stringent criteria, and the entire collection of 20,521 genomes (extended set).            
Considerations regarding the apparent reduction in allele frequency of polymorphic sites at            
the ends of the genome (see above), prompted us to exclude these sites from the analyses                
of the extended set. 
Irrespective of the dataset considered (Figure 1A, Supplementary Figure S2A), our criteria            
consistently identified 12 clusters (C1-C12) and 4 super-clusters (SC1-SC4) (Table          
2,Supplementary Table S1). As outlined in Figure 1B (and Supplementary Figure S2B), each             
cluster and supercluster is defined by a characteristic molecular signature consisting of            
states at 2 to 9 high frequency variable sites. Cluster 1 is the only exception in this respect,                  
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since it is formed by genomes that are highly similar to the reference.  
A comparison of our proposed clustering systems with the current classifications of            
Nexstrain and GISAID (Table 2), shows that our method recapitulates all of the major groups               
of genomes defined by GISAID and Nextstrain, as well as identifies additional clusters             
undescribed by only one (clusters 9 and 10) or both (clusters 11 and 12) other classification                
methods. Importantly, although the novel clusters defined in this study are formed by a              
relatively limited number of genomes (243 and 315 respectively for cluster 11 and 12), they               
show a similar genetic distance from the reference genome as all the other previously              
defined larger clusters (Figure 1B). Notably, a heatmap of worldwide prevalence of            
SARS-CoV-2 types (Figure 2) shows that cluster 12 represents more than 40% of the              
genomes isolated in India, but shows only a very modest prevalence in all other countries               
worldwide. To facilitate the classification of newly sequenced SARS-CoV-2 genomes an           
automated software package that implements the criteria devised in the present study has is              
made publicly available at ​https://github.com/matteo14c/assign_CL_SARS-CoV-2 ​ .  
 
Of the 50 high frequency polymorphic sites included in our analyses 35 reach complete, or               
nearly complete fixation (relative AF ≥ 0.9) in at least one cluster (Table 1, Figure 1B). Of                 
these 35, only three variants (11083G->T; 14805C->T; 28311C->T) show an allele frequency            
≥ 0.01 in more than one super-cluster, while the remaining 32 have an AF≥0.01 in only one                 
super-cluster, and can be therefore considered super-cluster “specific”. These observations          
strongly support our hypothesis that high frequency variable sites, as defined here, are             
highly effective for the discrimination/classification of distinct types of SARS-CoV-2.  
Strikingly, 15 of the 35 sites that are fixed in and specific to at least one cluster are                  
predicted to be under positive (8) or negative (7) selection according to FEL or MEME (Table                
1). Although this observation might be suggestive of distinct phenotypic features/properties           
for the different SARS-CoV-2 types, as previously suggested by other authors [33-35], we             
remark that in the absence of experimental validations, these data should be interpreted very              
carefully.  
As shown in Figure 3 and consistently with previous reports, we observe a highly biased               
geographic distribution of SARS-CoV-2 genome types worldwide [27-32]. Indeed, while          
relatively similar proportions of each cluster/supercluster are observed in Asia, the majority            
of all viral genomes observed in other continents are assigned to super-cluster 3 (SC3,              
consisting of C5 to C8). Importantly, from Figure 2 we notice that there is a modest                
prevalence of SC3 in China, the country that is currently considered the origin of the               
outbreak, where it accounts for only 5.1 % of all the genome types therein observed.  
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 Spatio-temporal distribution of SARS-CoV-2 genome types and emergence of         
new types 
Phylogeographic analyses show a highly biased distribution of SARS-CoV-2 genomes          
worldwide (Figure 3). However, representatives of each super-cluster are already observed           
in different geographic regions of China - the presumed country of origin of the outbreak-               
within 25 days of the report of the first case of COVID19 in Wuhan (Supplementary Figure                
S3A). During the same time period, 3 distinct clusters of genomes, each belonging to a               
different super-cluster (SC1, SC2 and SC4), are already observed in Wuhan (Supplementary            
Figure S3B). Assuming a constant evolutionary rate of SARS-CoV-2, and based on the             
average genetic distances of 52 SARS-CoV-2 genomes isolated in China during the early             
phases of the pandemic (prior to January 20th), we calculated that SARS-Cov-2 might have              
been circulating undetected in humans at least since August-November 2019, that is 82.3 ​±              
40.4 days before 26th December 2019, the collection date of the reference SARS-Cov-2             
genome (​Supplementary Table S4 ​). Strikingly, we notice that, among the 50 high frequency             
variants of SARS-CoV-2, 12 are also present in one or more genomes of SARSr-CoV-2              
isolated from bat and/or pangolin specimens (Supplementary Figure S4). This last           
observation suggests the presence of a much higher unexplored diversity shared by            
SARS-CoV-2 and  SARSr-CoV-2 viral genomes.  
 
To investigate possible scenarios of emergence of novel genome types, the frequency            
distribution of the 50 high prevalence alleles (AF ≥ 0.01) was calculated at intervals of 10                
days since 26th Dec 2019 (the collection date of the reference genome) separately for each               
of the 4 super-clusters and for the 12 clusters. Within clusters, distributions of allele              
frequency are highly stable and do not change over time (Supplementary Figures S5, S6,              
S7). On the contrary 27 alleles show a rapid emergence and an almost immediate fixation in                
each viral super-cluster (Figure 4 Supplementary Table S5 Supplementary Table S6). The            
most notable examples of this pattern are genomic positions 1059, 25563 and 14408 in SC3               
and 17747, and 17858 in SC2. Strikingly, 23 out of the 27 alleles rapidly emerging/fixed in                
super-clusters correspond with polymorphic sites specific to and completely fixed (AF >0.9)            
within one or more clusters (Supplementary Table S6). This suggests that the early             
emergence of novel clusters of virus could be used to detect changes of allele prevalence in                
the whole viral population.  
Strikingly, several clusters of SARS-CoV-2 genomes are not observed during the initial            
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phases of the pandemics and seem to emerge at a later time (Supplementary figures S5,               
S6, S7). Using an arbitrary threshold of time ≥60 days after the collection of the reference                
genome (26th Dec 2019), clusters have been divided in "late" (C3, C4, C6, C7, C8, C9, C10,                 
C12: appearing after 60 days) and "early" (C1, C2, C5, C11: appearing before 60 days)               
(Table 3). We found that "early" clusters have a probable origin in China, as observed in the                 
comparison of the phenetic patterns and the localities of the first 50 isolates (in terms of                
date) of each cluster (see Supplementary Figure S8). Interestingly, 6 of the 8 "late" clusters               
are likely to have originally emerged outside China (C4, C6, C7, C8, C10, C12) (Figure 2,                
Supplementary Figure S9). Overall, the low levels of variability of SARS-CoV-2, the            
emergence of novel genome types at different times during the pandemic, and the highly              
biased phylogeographic distribution (Figure 2), suggest that novel genome types of the “late”             
pandemic phases likely derived from the fixation of novel alleles in “early” pre-existent types. 
We speculate that several possible alternative evolutionary processes can explain this           
pattern of rapid allele fixation, including genetic drift and founder effects [55-56], convergent             
evolution, and/or rapid selection of standing variation for the adaptation to a novel             
environment [57]. To discriminate between these scenarios, we reasoned that while founder            
effects and selection should be associated with an overall reduction in genomic diversity of              
relevant viral sub-populations population, convergent evolution should not alter the          
underlying allele frequency distribution of the population (except at the sites under selection).             
We then compared the overall allele diversity between batches of genomes from all the              
clusters forming the super-clusters SC2 and SC3, batches equivalent both in number and             
timescale (see Materials and Methods) (Figure 5A). SC1 was not considered due to being              
composed of a single cluster, while considerations regarding the limited availability of            
genomes matched by collection date prompted us to exclude SC4 from these analyses. The              
results show a statistically significant (p-value Wilcoxon 1.3e-07 for C3, 1.5e-07 for C4 and              
9.21e-08, 1.21e-07 and 1.13e-07 for C6, C7 and C8 respectively) reduction of genetic             
diversity for late clusters (i.e. clusters emerging after ≥60 days) compared to early clusters.              
Importantly (Figure 5B, Table3), we observe that evolutionary rates are highly homogeneous            
and do not show detectable changes between clusters, suggesting that reduced diversity of             
late clusters is not associated with a reduction of evolutionary rates. According to our              
starting hypothesis, and in the light of the strong phylogeographic bias, these results suggest              
that the emergence of novel SARS-CoV-2 genome types is unlikely to be driven by              
widespread convergent evolution and independent fixation of advantageous substitutions. 
Remarkably, our analyses do not support an increased genomic diversity for clusters            
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included in SC3 (Figure 5A), although their common molecular signature, i.e., the prevalent             
polymorphic site at position 14408 in the nsp12 gene (RdRp), was previously described as              
associated with an increased genomic variability (​Pachetti et al. [33]​). We speculate that             
biased/incomplete sampling of SC3 during the early phase of the pandemic, and the fact that               
Pachetti et al compared raw non-normalized genetic distances (instead of normalized           
evolutionary rates) are the most likely explanation for this discrepancy.  
 
 
Distribution of variable sites along the SARS-Cov-2 genome  
Patterns of genomic variability were established on sliding windows of 100 bp in size and               
overlapping by 50 bp, for all the clusters and super-clusters defined in this study. As shown                
in Figure 6 and Supplementary Figure S10 , the observed patterns are remarkably similar              
between all the clusters and super-clusters, suggesting common patterns of variation.           
Density of polymorphic sites is significantly enriched (Adjusted Fisher test p-value ≤1e-15            
and ≤1e-12 respectively) in both the 5’ and 3’ UTR regions, while protein coding loci (CDS)                
show less variability. Strikingly, a single genomic region in the 3’ UTR accumulates ~10x              
more mutations than any CDS, ~ 2x more than any other UTR region, and is the single most                  
variable region in the genome of SARS-CoV-2 (Figure 7A). This highly variable genomic             
region is associated with a conserved secondary structure (Figure 7A), already known in             
literature and referred to as s2m. 
S2m is a 41-nucleotide genetic element with a highly conserved secondary - as well as               
primary and tertiary - structure, and has been described in several families of             
single-stranded RNA viruses, including Astroviridae, Caliciviridae, Picornaviridae and        
Coronaviridae [58]. The molecular function of this potentially mobile structural element is not             
well understood. Current hypotheses include hijacking of host protein synthesis through           
interactions with ribosomal proteins [59], and RNA interference (RNAi) via processing of the             
s2m elements into a mature microRNA [60]. In coronaviruses, the highly conserved nature             
s2m has also allowed the development of a PCR-based virus discovery strategy [61]. 
As outlined in Figure 7B, compared to the consensus secondary structure of s2m described              
in the Rfam database, the reference genome of SARS-CoV-2 harbors a nucleotide            
substitution at a highly conserved and structurally important position, with possible impacts            
on structural stability (the T at the SARS-CoV-2 genomic position 29,758, indicated by an              
arrow in Figure 7A). Secondary structure predictions, based on the Vienna RNAfold            
program, suggest that of all the secondary structures obtained by the possible 129 single              
nucleotide substitutions in the presumably ancestral sequence of s2m as observed in the             
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genome of RaTG13 SARSr-CoV-2, this would be the second less stable structure in terms              
of reduction of structural stability (Supplementary Table S7). Based on this observation and             
on the high levels of variation of the entire s2m region, it is tempting to speculate that s2m                  
could be under diversifying selection in SARS-CoV-2. Strikingly, we observe that the G->T             
substitution at 29,742, which is a hallmark of cluster C11, would result in a substantially               
increased stability of s2m (Supplementary Table S7), with an MFE that becomes            
substantially lower than that of the s2m structure of the reference genome. Conversely, other              
2 recurrent substitutions in s2m, 29,742 G->A and 29,734 G->T, which do not reach fixation               
according to our criteria (having allele frequency ≤ 0.01) and are not associated with a               
specific cluster of SARS-CoV-2 genomes, are predicted to result only in a marginal decrease              
of the MFE of the s2m secondary structure (Supplementary Table S7). Interestingly, we             
notice (​Figure 7C​) that the same consideration applies to the majority of the nucleotide              
substitutions that are observed in the SARS-CoV-2 s2m element. Indeed, with respect to the              
background of all possible nucleotide substitutions that could occur in s2m of the             
SARS-CoV-2 reference genome, the set of variants that is actually found in extant             
SARS-CoV-2 genomes seems to produce a less stable secondary structure.  
A co-folding analysis of all distinct variants of the s2m elements found in the 11,633               
complete and high quality genomes - according to the criteria defined in this study - suggest                
a very degenerate secondary structure of s2m in SARS-CoV-2 (Figure 7D).  
Notably while a substitution that restores the presumably ancestral state of s2m (i.e., the              
secondary structure of RaTG13 SARSr-CoV-2) is observed (29753 T->G), this substitution is            
associated only with a very limited number of genomes (AF=0.0012). 
 
 
Discussion 
Development of effective methods for the study of molecular data and the characterization of              
pathogens genomic sequences and their evolution are of fundamental importance for           
monitoring the spread and evolution of pathogens. The GISAID and Nextstrain portals            
currently represent two invaluable resources for the sharing of genomic data of            
SARS-CoV-2. Although both GISAID and Nexstrain incorporate methods for the          
classification of SARS-CoV-2 genomic sequences, these systems are not ideal, since they            
lack transparent and systematic sets of rules and can not easily be applied for the               
systematic classification of novel genomic sequences.  
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In the current study we propose a rational and highly reproducible approach for the              
classification of SARS-CoV-2 genomes, inspired by Multi Locus Strain Typing (MLST), a            
molecular approach commonly used for the classification of pathogens [42]. Building on a             
highly informative set of variable sites, which show high prevalence in the viral population,              
our system is conceptually simple and represents a general and robust alternative to             
methods based on phylogenetic analyses. Applying our system to the entire collection of             
genomic sequences, as available on 28th May 2020, we derive interesting observations            
concerning evolutionary patterns of SARS-CoV-2. 
By comparison of more than 20,000 complete or nearly complete genomic sequences we             
observe a reduced level of variability and a relatively low mutation rate (1.84 sites per 10 ​-3 nt                 
per year) in SARS-CoV-2. Although this is consistent with previous reports of low             
evolutionary rates in coronaviruses and SARSr-CoVs [26-50], considerations regarding the          
rapid spread of SARS-CoV-2, and possible biases in sampling of genomes from different             
areas of the world, suggest that this estimate should be treated carefully, especially since it               
is not known whether evolutionary rates are expected to remain stable in the event of a rapid                 
expansions of the viral population. This notwithstanding, the presence of different types of             
SARS-CoV-2 genomes during the early phases of the pandemic (within 25 days of the report               
of the first case of COVID19 in Wuhan) in several distinct geographic regions of China,               
coupled with low levels of genomic variability, is suggestive of an early circulation of              
SARS-CoV-2 in humans, probably well before the major outbreak of COVID19 in Wuhan.             
The evolutionary rates estimated in this study, coupled with the number of observed             
polymorphic sites would retrospectively date the spillover of SARS-CoV-2 in humans to            
August-November 2019, an estimate that is consistent with other recent studies [62].            
Careful monitoring of the evolutionary rates of SARS-CoV-2 over a longer period of time,              
and ideally also on an unbiased/matched number of genomes isolated from different            
geographic areas, are required to confirm these findings.  
In this respect, the fact that a relevant number of SARS-CoV-2 high frequency polymorphic              
sites are observed even in viral strains isolated from pangolins and bats specimens             
highlights an unexplored diversity shared by SARS-CoV-2 and SARSr-CoV-2 viral          
genomes. This suggests that additional sampling of a larger number of non-human            
specimens is required to reconstruct a more complete phylogeny and to possibly trace back              
the “original” spillover event. Indeed, notwithstanding the high levels of similarity to            
SARS-CoV-2 (in the order of 97%), RaTG13, the most closely related viral genome isolated              
from a bat specimen, is supposed to have diverged from SARS-CoV-2 more than 25 to 40                
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years ago [63].  
Our classification system, based on 50 high frequency polymorphic sites, identifies a total of              
12 distinct clusters and 4 super-clusters of SARS-CoV-2 genome types, all having a highly              
biased phylogeographic distribution (Figure 2-3). We note that several polymorphic sites that            
are specifically associated (completely fixed) with clusters and super-clusters are predicted           
to be either under positive or negative selection according to state of the art methods for the                 
study of evolutionary constraints in protein coding genes (Table 1). Interestingly, several of             
these sites have been previously highlighted by other studies and tentatively associated with             
increased virulence and/or increased mutation rates of SARS-CoV-2 [33-35].  
While fixation of advantageous variants has previously been proposed as an effective and             
widespread mechanism for the rapid increase of the fitness of a viral population [64], it               
should be stressed that in the absence of extensive experimental validation, the functional             
relevance of these genomic variants remains unclear at present. Especially, since reduced            
levels of variability, high levels of recombination and, particularly, biased sampling of            
genomic sequences, could impair the accuracy of methods based on phylogenetic           
reconstruction of ancestral states for the identification of possible evolutionary signatures           
[65-66]. In this respect, it should be stressed that our observation of reduced genetic              
variability of “late” viral clusters belonging to SC3 and SC4 (Figure 5A), coupled with the               
highly biased phylogeographic distribution of SARS-CoV-2 genome types (Figure 2-3), are           
more consistent with genetic drift and founder effects rather than ongoing adaptive selection.             
However, the hypothesis that genetic drift accounts for a great part of SARS-CoV-2             
variability does not exclude selection having driven a small number of fixed substitutions, so              
sites identified as candidates for selective evolution warrant further functional          
characterization both ​in vitro​ and eventually ​in vivo​. 
Notably, we observe a highly consistent pattern of nucleotide substitution in SARS-CoV-2            
genomes between all clusters and superclusters, characterized by an increased variability at            
UTRs, in spite of the fact that a significant proportion of genomic assemblies annotated as               
“full-length” in GISAID are incomplete at the terminal ends. Although this incomplete            
representation of genomic sequences does not affect the classification system proposed in            
this study, it might result in an inaccurate/incomplete representation of ongoing evolution of             
SARS-CoV-2. This is exemplified by the s2m element, a highly conserved secondary            
structure element located in the 3’ UTR which carries a substitution in the reference genome               
of SARS-CoV-2 that destabilizes the secondary structure and is possibly deleterious. In the             
absence of clear data on a function to be experimentally tested, it is very difficult to                
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speculate whether the s2m of SARS-CoV-2 maintains the same functional activity. However,            
the substantial increase of genomic variability observed in the s2m locus, compared with the              
rest of the genome, suggests that this element might be subject to ongoing widespread              
diversifying selection in SARS-CoV-2, or at least have lost significant purifying constraints.            
Patterns of single nucleotide substitutions in s2m provide contrasting evidence concerning           
the evolutionary patterns of this secondary structure element in SARS-CoV-2, as the most             
prevalent substitutions (29,742 G->T) seems to be associated with a considerable increase            
in secondary structure stability, but the majority of the substitutions observed in extant             
SARS-CoV-2 genomes are not optimal in terms of the recovery of a highly stable secondary               
structure.  
In conclusion several questions concerning the mechanisms of evolution and the phenotypic            
characteristics of SARS-CoV-2 (increased/decreased virulence) remain open, in the         
absence of rigorous experimental validations. However, by allowing a rapid and systematic            
classification of SARS-CoV-2 genome types, the approach here presented can be           
extremely useful for a fine grained monitoring of the prevalence of different types of              
SARS-CoV-2 worldwide, but also for the study of the molecular processes that underlie the              
emergence of novel viral types 
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Table Legends 
 
Table 1: ​ List of high frequency polymorphic sites. 
Pos: genomic position on the reference genome. Ref: reference allele. Alt: alternative allele.             
Funct. element: functional genomic element. AA residue: amino acid residue position for            
protein coding genes. aa sub: amino acid residue substitution for protein coding genes. AF:              
Estimated allele frequency on the set of high quality genomes, expressed as %. FEL:              
Selection according to FEL: NA=not applicable, yes=under selection, no=not under          
selection. MEME: Selection according to Meme: NA=not applicable, yes=under selection,          
no=not under selection. Type: type of selection, NA=not applicable. Completely fixed cluster:            
list of clusters where the polymorphic site reaches complete fixation (AF>0.9). Fixed            
supercluster: list of super-clusters where the polymorphic site is fixed (AF >0.01) 
 
Table 2: ​Comparison of our classification system with GISAID and Nextstrain classification            
available on June 12th 2020. Size(HQ): number of genomes of the high quality (HQ) dataset               
of 11,633 genomes assigned to every cluster. Size(complete): number of genomes of the             
entire dataset (complete) of 20,581 genomes assigned to every cluster. NA= not applicable,             
the group is not defined.  
 
Table 3: ​ Time of emergence and classification of clusters in early and late. 
Presumed time of emergence: Time of emergence of the cluster, in days with respect to the                
collection date of the reference genome (time 0 = 26th December 2019). Late/Early:             
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classification of clusters in “early” (emergence of the cluster before time T60), and “late”              
emergence of the cluster after time T60). Increased variability: P-value for increased            
variability of evolutionary rates in the cluster according to a Wilcoxon Sum and Rank Test 
 
Figures Legends: 
 
Figure 1 
A) Heatmap of presence/absence of 50 high frequency polymorphic sites (AF >0.01) in             
11,633 “high quality” complete SARS-CoV-2 genomes, assigned to the 12 clusters here            
identified. Genomic coordinates are represented on the X axis. Pink indicates a reference             
allele, Red an alternative allele for that site. The panels on the left indicate cluster               
memberships, with a different colour assigned to each cluster. Dotted lines delineate            
super-clusters. B) Bubbleplot of allele frequency of the 50 high frequency polymorphic sites             
in individual clusters. Color codes according to 1A. The dendrogram on the left indicates              
clusters with similar allele frequency profiles. The size of each “bubble” is proportional to the               
frequency of that allele in a given cluster. Barplot on the right panel indicates the number of                 
genomes assigned to every cluster, scaled by logarithm base 10. 
Figure 2 
Heatmap of worldwide prevalence of SARS-CoV-2 genome types. Only countries for which            
at least 50 distinct genomes of SARS-CoV-2 are available in a public repository are shown.               
Color codes on the left indicate individual clusters, according to Figure 1. The dendrogram              
on the top delineates groups of countries with a similar prevalence of clusters of              
SARS-CoV-2 genomes. 
Figure 3 
Pie-chart of prevalence of types of SARS-CoV-2 in different continents. Outer circles indicate             
the prevalence of super-clusters.  Color code as in Figure 1 
Figure 4 
Bubbleplots of allele frequency in the 4 super-clusters of SARS-CoV-2 genomes, at different             
intervals in time. Each bubbleplot displays the allele frequency of the 50 high frequency              
polymorphic sites calculated at different- non-overlapped intervals of 10 days. (“T_” with time             
0= 26th December 2019). The size of each bubble is proportional to the allele frequency.               
Color codes according to clusters as in Figure 1. The barplots on the top indicate the number                 
of genomes of each super-cluster observed at each time interval considered, scaled by             
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logarithm base 10. 
 
Figure 5  
A) Violin plots of genetic diversity of late and early clusters of SARS-CoV-2 genomes              
assigned to super-cluster CS2 and super-cluster CS3. A vertical line is used to separate              
early and late clusters. P-values, for the significant reduction of genetic diversity (reduced             
number of distinct polymorphic sites per genome) are reported on the top of each violin plot. 
B) Violin plot of substitution rates of the 12 clusters of SARS-CoV-2 genomes identified in               
this study. Color codes according to Figure 1. 
Figure 6 
Plot of genomic variability, calculated as the proportion of variable sites identified in             
overlapping genomic windows of 100 bp in the four super-clusters SC1-SC4. Genomic            
coordinates are represented on the X axis, number of variable sites per window on the Y                
axis 
Figure 7 
Analysis of variability and structural stability of the s2m secondary structure element. 
A) Barplot of variability of different categories of genomic elements in the genome of              
SARS-CoV-2. Variability is reported as the proportion of polymorphic sites. B) Consensus            
secondary structure of the s2m element of coronaviruses according to the RFAM model             
RF00164 (​https://rfam.org/family/RF00164 ​). The arrow indicates the nucleotide substitution        
observed in the s2m of the reference genome of SARS-CoV-2 (position 29,758). 
C) Boxplot of MFE (minimum free energy) of predicted s2m secondary structures. Initial:             
MFE of the s2m element in the SARS-CoV-2 reference genome. Not observed: MFE of              
secondary structures associated with single nucleotide substitutions that are not observed in            
s2m of extant SAR-CoV-2 genomes. Observed: MFE of secondary structures associated           
with nucleotide substitutions found in the s2m element of extant SAR-CoV-2 genomes 
D) Prediction of secondary structure co-folding of s2m of SARS-CoV-2 according to the             
Rscape program. The structure has been derived by alignment of all the 31 distinct variants               
of the s2m element found in the 11,633 high quality complete genomes considered in this               
study. Color codes are used to indicate the level of conservation of single nucleotide              
residues according to the convention used in RFAM (white <=50%, gray >50% and <= 75%,               
black >75% and < 90%, red>=90% ) 
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Supplementary Table Legends 
Supplementary Table S1: Genomic sequence metadata​. High qual: Classification of high           
quality genomes according to the criteria defined in this work: 1= high quality, 0=not of high                
quality. Time wrt T0: Time interval in days between the collection date of that genome and                
26th December 2019, i.e., the collection date of the reference genome. Release date: date              
of release in GISAID. Cluster: cluster assigned to each genome according to the             
classification system defined in this study.  
Supplementary Table S2: Functional annotation of nucleotide variants ​. Pos: genomic          
position on the reference genome. Ref: reference sequence. Alt: alternative sequence.           
HQ_seq: variant observed in one or more “high quality” genome, 1=yes, 0=no. Number of              
genomes: Number of distinct genomic sequences that carry the variant. Genomic element:            
Functional genomic element (protein coding gene or UTR), with numbers corresponding to            
the relative position within that functional element. AA residue: amino-acidic residue in            
protein coordinates, NA=not applicable. AA change: Predicted change in protein sequence.           
NA=not applicable. Predicted FE: Predicted functional effect, with FDdel= Frameshift          
deletion, FSins=Frameshift insertion, NS=non synonymous substitution, S=synonymous       
substitution, Stop Gain= stop gain, Stop loss= stop loss. MEME/FEL: evidence for selection             
according to MEME or FEL. 
Supplementary Table S3: List of amino acid residues under selection according to            
MEME and FEL. FEL: Under selection according to FEL 1=True, 0=False. MEME: Under             
selection according to MEME 1=True, 0=False.  Kind: Type of selection (Positive/negative). 
Supplementary Table S4: Average genetic distances and estimated divergence times          
of 52 genomic sequences isolated in China within 25 days of the collection of the               
reference genome. ​AvG dist: Average genetic distance. Avg dist months: Average distance            
in months. Interval: Interval (in days) between the collection date of that genome and 26th               
December 2019, i.e., the collection date of the reference genome. 
Supplementary Table S5: Allele frequency of the 50 high frequency polymorphic sites            
in the 4 super-clusters of genomes defined in this study. ​“T_” indicates time expressed              
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in days, with time 0= 26th December  2019, i.e., the collection date of the reference genome 
 
Supplementary Table S6: List of 26 genetic variants fixed in a super-cluster after 60 or               
more days from the collection date of the reference genome (26th December 2019).             
Time: Time of fixation of the variant. AV-Prev: Average allele frequency in the super-cluster.              
VAR-Prev: Variance of allele frequency in the super-cluster. Completely fixed: Complete           
fixation in one or more clusters (AF>0.9),1=True, 0=False 
Supplementary Table S7: Analysis of stability of secondary structure of the s2m            
element. ​Rel pos: relative position in s2m. Gen pos: genomic position. Sub: Nucleotide             
substitution. MFE: MFE. Observed: Observed in an actual genome sequence: 1=True,           
0=False. Sub_RaTG13: Nucleotide substitution in the s2m of the RaTG13 genome.           
MFE_RaTG13: MFE in the s2m of the RaTG13 genome. The first row indicates the MFE               
(minimum free energy) of s2m secondary structure found in the reference genome of             
SARS-CoV-2 and in the RaTG13 SARSr-CoV-2 genome assembly. NA=not applicable 
 
Supplementary Figure legends 
Supplementary Figure S1: ​Phylogeny and classification of SARS-CoV-2 genomes         
according to the GISAID and Nextstrain portals. A) Nextstrain,         
https://nextstrain.org/ncov/global accessed June 12th 2020 B) GISAID       
https://www.epicov.org/epi3/frontend# ​, from GISAID “analysis update”, accessed June 12th        
2020. 
 
Supplementary Figure S2: A) Heatmap of presence/absence of 46 high frequency           
polymorphic sites (AF >0.01) in the complete collection of 20,521 SARS-CoV-2 genomes,            
assigned to the 12 clusters here identified. Genomic coordinates are represented on the X              
axis. Pink indicates a reference allele, Red an alternative allele for that site. The panels on                
the left indicate cluster memberships, with a different colour assigned to each cluster.             
Dotted lines delineate superclusters.  
B) Bubbleplot of allele frequency of the 46 high frequency polymorphic sites in individual              
clusters. Color codes according to Figure 1A. The dendrogram on the left indicates clusters              
with similar allele frequency profiles. The size of each “bubble” is proportional to the              
frequency of that allele in a given cluster. Barplot on the panel indicates the number of                
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genomes assigned to every cluster, scaled by logarithm base 10. 
 
Supplementary Figure S3:  
A) Prevalence of super-clusters and clusters in four distinct regions of China, for which more               
than 20 genomic sequences were collected within 25 days of the collection date of the               
reference genome (26th December 2019). Pie-charts represent prevalence of clusters. Outer           
circles indicate the prevalence of super-clusters.  
B) Prevalence of super-clusters and clusters in Wuhan city within 25 days of the collection               
date of the reference genome (26th December 2019). Pie chart as described above. In the               
heatmap genomic coordinates are represented on the X axis. Pink indicates a reference             
allele, red an alternative allele for. Panels on the left indicate cluster memberships, with a               
different colour assigned to each cluster. Color codes according to Figure 1. Collection dates              
are reported on the rows. 
Supplementary Figure S4: Phenetic patterns of the 50 high frequency SARS-CoV-2           
alleles, in SARSr-CoVs-2​. SARS-CoV-2 genomic positions for the 50 high frequency           
(AF>=0.01) polymorphic sites of SARS-CoV-2 are represented on the X axis. Pink indicates             
a reference allele, red an alternative allele. GISAID accession numbers and species            
(pangolin or bat) of SARSr-CoVs-2 sharing some of these sites  are reported on the rows. 
Supplementary Figure S5: Bubbleleplot of allele frequency in individual clusters of           
super-cluster SC2. ​Allele frequency of the 50 high frequency polymorphic sites in            
super-cluster SC2, calculated at different and non-overlapped intervals of 10 days (“T_”, with             
time 0 = 26th December 2019, i.e., the collection date of the reference genome). Color               
codes according to Figure 1. The barplots on the top indicate the number of genomes of                
each super-cluster observed at each time interval considered. 
Supplementary Figure S6: Bubbleplot of allele frequency in individual clusters of           
super-cluster SC3. Allele frequency of the 50 high frequency polymorphic sites in            
super-cluster SC3, calculated at different and non-overlapped intervals of 10 days (“T_”, with             
time 0 = 26th December 2019, i.e., the collection date of the reference genome). Color               
codes according to Figure 1. The barplots on the top indicate the number of genomes of                
each super-cluster observed at each time interval considered. 
Supplementary Figure S7: Buppleplot of allele frequency in individual clusters of           
super-cluster SC4. Allele frequency of the 50 high frequency polymorphic sites in            
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super-cluster SC4, calculated at different and non-overlapped intervals of 10 days (“T_”, with             
time 0 = 26th December 2019, i.e., the collection date of the reference genome). Color               
codes according to Figure 1. The barplots on the top indicate the number of genomes of                
each super-cluster observed at each time interval considered. 
Supplementary Figure S8: Phenetic patterns and geographic area of the first 50            
genomes for each “early” cluster. ​Each heatmap displays presence/absence of the 50            
high frequency polymorphic sites (AF >0.01, identified in the 11,633 “high quality” complete             
SARS-CoV-2 genomes) in the first 50 genomes, in terms of date, of each early cluster​.               
Genomic coordinates are represented on the X axis. Pink indicates a reference allele, red an               
alternative allele for that site. Early cluster as defined in Table 3. Panels on the left indicate                 
continents: yellow=Asia, blue=Europe, pink=Africa, green=North America, orange=South       
America, purple=Oceania. Country and date of collection are reported on the rows. 
Supplementary Figure S9: Phenetic patterns and geographic area of the first 50            
genomes for each “late” cluster. ​Each heatmap displays presence/absence of the 50 high             
frequency polymorphic sites (AF >0.01, identified in 11,633 “high quality” complete           
SARS-CoV-2 genomes) in the first 50 genomes, in terms of date, of each late cluster.               
Genomic coordinates are represented on the X axis. Pink indicates a reference allele, red an               
alternative allele for that site. Panels on the left indicate continents: yellow=Asia,            
blue=Europe, pink=Africa, green=North America, orange=South America, purple=Oceania.       
Country and date of collection are reported on the rows. 
Supplementary Figure S10: ​Plot of genomic variability, calculated as the proportion of            
variable sites identified in overlapping genomic windows of 100 bp in the twelve clusters              
C1-C12 ​. Genomic coordinates are represented on the X axis, number of variable sites per              
window on the Y axis. Color codes according to Figure 1. 
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Table 1
Pos Ref Alt aa sub AF Fel Meme Type
36 C T 5'UTR:36 NA C->T 0.012 NA NA NA no 1
241 C T 5'UTR:241 NA C->T 0.684 NA NA NA 5;6;7;8 3
1059 C T nsp2:254 85 T->I 0.304 yes yes positive 8 3
1397 G A nsp2:592 198 V->I 0.016 no no no 11 4
1440 G A nsp2:635 212 G->D 0.032 no no no no 1
1605 ATG ... nsp2:800 267 Frameshift 0.033 no no no no 1
2416 C T nsp2:1611 537 Y->Y 0.031 yes no negative no 3
2480 A G nsp2:1675 559 I->V 0.057 no no no 10 4
2558 C T nsp2:1753 585 P->S 0.060 no no no 10 4
2891 G A nsp3:172 58 A->T 0.030 no no no no 1
3037 C T nsp3:318 106 F->F 0.681 yes no negative 5;6;7;8 3
6312 C A nsp3:3593 1198 T->K 0.022 no no no 12 4
8782 C T nsp4:228 76 S->S 0.184 yes no negative 2;3;4 2
9477 T A nsp4:923 308 F->Y 0.015 yes no positive 4 2
10097 G A nsp5:43 15 G->S 0.032 yes yes positive 6 3
11083 G T nsp6:111 37 L->F 0.196 yes yes positive 9;10;11;12 1;2;3;4
11916 C T nsp7:74 25 S->L 0.030 yes yes positive 8 3
13730 C T nsp12:290 97 A->V 0.027 yes yes positive 12 4
14408 C T nsp12:968 323 P->L 0.681 yes yes positive 5;6;7;8 3
14805 C T nsp12:1365 455 Y->Y 0.148 yes no negative 4;9;10 3;4
15324 C T nsp12:1884 628 N->N 0.041 yes no negative no 1
17247 T C nsp13:1011 337 R->R 0.050 yes no negative no 4
17747 C T nsp13:1511 504 P->L 0.111 no no no 9 4
17858 A G nsp13:1622 541 Y->C 0.113 no no no 3 2
Funct. 
element
AA 
residue
Completely 
Fixed 
Cluster
Fixed 
supercluster
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18060 C T nsp14:21 7 L->L 0.115 no no no 3 2
18877 C T nsp14:838 280 L->L 0.051 yes no negative no 3
18998 C T nsp14:959 320 A->V 0.021 no no no 8 3
20268 A G nsp15:648 216 L->L 0.084 yes no negative 5 3
23403 A G spike:1841 614 D->G 0.644 no no no 5;6;7;8 3
23731 C T spike:2169 723 T->T 0.033 yes no negative 6 3
23929 C T spike:2367 789 Y->Y 0.022 no no no 12 4
24034 C T spike:2472 824 N->N 0.019 yes no negative 2 2
25563 G T orf3A:171 57 Q->H 0.303 no no no 7;8 3
25979 G T orf3A:587 196 G->V 0.015 no no no 4 2
26144 G T orf3A:752 251 G->V 0.141 no no no 9;10 4
26735 C T geneM:213 71 Y->Y 0.021 no no no no 3
27046 C T geneM:524 175 T->M 0.035 no no no no 3
27964 C T orf8:71 24 S->L 0.045 no no no no 3
28144 T C orf8:251 84 L->S 0.186 no no no 2;3;4 2
28311 C T geneN:38 13 P->L 0.026 yes yes positive 12 2;4
28657 C T geneN:384 128 D->D 0.015 no no no 4 2
28688 T C geneN:415 139 L->L 0.015 yes no negative 11 4
28854 C T geneN:581 194 S->L 0.031 no no no no 3
28863 C T geneN:590 197 S->L 0.016 no no no 4 2
28881 GGG AAC geneN:608 203 RG->KR 0.394 no no no 6 3
29540 G A NA NA NA 0.021 NA NA NA 8 4
29553 G A NA NA NA 0.026 NA NA NA no 3
29711 G T 3'UTR:37 NA NA 0.013 NA NA NA no 1
29742 G T 3'UTR:68 NA NA 0.017 NA NA NA 11 4
29870 C A 3'UTR:196 NA NA 0.017 NA NA NA no 1;4
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Table 2
Cluster name Super Cluster Size (HQ)
1 1 1140 1610 L 19A
2 2 465 636 S 19B
3 2 1068 1474 S 19B
4 2 124 227 S 19B
5 3 3965 8102 GR 20A+20B
6 3 133 322 GR 20A+20B
7 3 3593 5710 GH 20A+20C
8 3 182 369 GH 20A+20C
9 4 387 928 V NA
10 4 218 588 V NA
11 4 154 242 NA NA
12 4 204 313 NA NA
Size 
(complete)
Equivalent group 
GISAID
Equivalent group 
Nextstrain
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 Table 3
Cluster Late/early Increased variability
1 10 Early 0.8821
2 20 Early 0.8917
3 60 Late 0.9132
4 70 Late 0.6151
5 40 Early 0.667
6 80 Late 0.882
7 60 Late 0.9146
8 80 Late 0.6871
9 60 Late 0.8701
10 70 Late 0.882
11 30 Early 0.8512
12 70 Late 0.6912
Presumed time of 
emergence
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